Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Zylox-Tonbridge Medical Technology Co., Ltd. Class H ( (HK:2190) ) just unveiled an update.
Zylox-Tonbridge Medical Technology Co., Ltd. successfully held its 2024 Annual General Meeting (AGM) on May 30, 2025, where all proposed resolutions were approved unanimously. The meeting was conducted in compliance with relevant laws and regulations, with a significant portion of the company’s shares represented in the voting process, indicating strong shareholder support and engagement.
The most recent analyst rating on (HK:2190) stock is a Buy with a HK$18.60 price target. To see the full list of analyst forecasts on Zylox-Tonbridge Medical Technology Co., Ltd. Class H stock, see the HK:2190 Stock Forecast page.
More about Zylox-Tonbridge Medical Technology Co., Ltd. Class H
Zylox-Tonbridge Medical Technology Co., Ltd. is a company incorporated in the People’s Republic of China, operating in the medical technology industry. The company is focused on developing and providing medical devices and solutions, with a market presence that includes both domestic and international stakeholders.
Average Trading Volume: 817,950
Technical Sentiment Signal: Buy
Current Market Cap: HK$6.16B
Learn more about 2190 stock on TipRanks’ Stock Analysis page.